CBS-0550

From HandWiki - Reading time: 3 min

Short description: Chemical compound
CBS-0550
CBS-0550.svg
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC20H23F4N3O
Molar mass397.418 g·mol−1
3D model (JSmol)

CBS-0550 is a drug developed by Taisho Pharmaceutical, which acts as a potent and selective cannabinoid CB2 receptor agonist, with 1400x selectivity for CB2 over the related CB1 receptor. Unlike most cannabinoid agonists, CBS-0550 has good solubility in water, and in animal studies it was found to produce analgesic and anti-hyperalgesic effects.[1] A number of related compounds have been developed with similar properties.[2]

See also

References

  1. "Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action". Bioorganic & Medicinal Chemistry 16 (3): 1111–24. February 2008. doi:10.1016/j.bmc.2007.10.087. PMID 18006322. 
  2. "N-Alkylidenearylcarboxamides as new potent and selective CB(2) cannabinoid receptor agonists with good oral bioavailability". Bioorganic & Medicinal Chemistry Letters 17 (22): 6299–304. November 2007. doi:10.1016/j.bmcl.2007.09.004. PMID 17884496. 




Licensed under CC BY-SA 3.0 | Source: https://handwiki.org/wiki/Chemistry:CBS-0550
9 views | Status: cached on July 16 2024 08:33:01
↧ Download this article as ZWI file
Encyclosphere.org EncycloReader is supported by the EncyclosphereKSF